PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Apyx Medical Corporation (APYX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US03837C1062

CUSIP

03837C106

Sector

Healthcare

IPO Date

Jan 1, 1987

Highlights

Market Cap

$61.74M

EPS (TTM)

-$0.82

Total Revenue (TTM)

$52.84M

Gross Profit (TTM)

$19.78M

EBITDA (TTM)

-$22.84M

Year Range

$0.97 - $2.80

Target Price

$2.83

Short %

0.73%

Short Ratio

5.49

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
APYX vs. GHC
Popular comparisons:
APYX vs. GHC

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Apyx Medical Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%JulyAugustSeptemberOctoberNovemberDecember
18.56%
9.23%
APYX (Apyx Medical Corporation)
Benchmark (^GSPC)

Returns By Period

Apyx Medical Corporation had a return of -36.64% year-to-date (YTD) and -34.39% in the last 12 months. Over the past 10 years, Apyx Medical Corporation had an annualized return of -7.85%, while the S&P 500 had an annualized return of 11.11%, indicating that Apyx Medical Corporation did not perform as well as the benchmark.


APYX

YTD

-36.64%

1M

14.88%

6M

22.06%

1Y

-34.39%

5Y*

-26.75%

10Y*

-7.85%

^GSPC (Benchmark)

YTD

25.25%

1M

0.08%

6M

9.66%

1Y

25.65%

5Y*

13.17%

10Y*

11.11%

Monthly Returns

The table below presents the monthly returns of APYX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-14.50%-6.25%-35.24%5.15%15.38%-18.79%1.49%-2.21%-6.77%-5.65%37.61%-36.64%
202324.79%11.30%-11.38%18.06%86.18%-20.54%11.13%-16.64%-31.33%-28.44%3.06%11.02%11.97%
2022-10.30%-12.00%-35.47%-42.27%61.01%-3.46%61.43%-39.43%-21.64%11.36%-64.80%32.95%-81.75%
202129.03%12.49%-7.56%4.87%-3.36%5.31%-12.71%31.22%17.27%3.25%-6.08%-4.54%78.06%
2020-10.28%-20.29%-40.66%-5.29%30.59%25.00%-19.10%2.23%2.61%27.81%27.08%-5.88%-14.89%
201933.80%-19.03%-10.11%-20.92%20.84%11.44%7.74%-1.80%-4.78%-2.51%20.91%6.02%30.56%
2018-8.46%3.78%20.24%17.51%12.32%10.97%11.03%10.56%32.96%-25.77%34.16%-8.35%149.23%
20175.29%-15.61%-16.30%1.12%-23.33%19.32%2.43%-5.93%42.02%15.38%-24.87%-11.26%-27.58%
20164.76%-14.09%-11.64%17.96%-19.29%3.14%12.80%122.16%26.76%5.76%-22.14%-16.32%70.95%
2015-3.53%-4.79%-29.29%29.62%-6.71%-3.46%-17.20%-4.76%-11.36%-2.56%2.11%8.25%-42.93%
201429.30%13.31%23.81%1.28%16.96%-21.43%7.99%8.16%-5.90%-1.25%-0.36%-6.27%71.16%
201313.64%-2.55%23.13%-1.52%1.85%-10.88%1.69%0.33%-6.31%-6.38%-20.42%2.33%-11.16%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of APYX is 32, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of APYX is 3232
Overall Rank
The Sharpe Ratio Rank of APYX is 2929
Sharpe Ratio Rank
The Sortino Ratio Rank of APYX is 3434
Sortino Ratio Rank
The Omega Ratio Rank of APYX is 3535
Omega Ratio Rank
The Calmar Ratio Rank of APYX is 2727
Calmar Ratio Rank
The Martin Ratio Rank of APYX is 3333
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Apyx Medical Corporation (APYX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for APYX, currently valued at -0.37, compared to the broader market-4.00-2.000.002.00-0.372.07
The chart of Sortino ratio for APYX, currently valued at 0.00, compared to the broader market-4.00-2.000.002.004.000.002.76
The chart of Omega ratio for APYX, currently valued at 1.00, compared to the broader market0.501.001.502.001.001.39
The chart of Calmar ratio for APYX, currently valued at -0.36, compared to the broader market0.002.004.006.00-0.363.05
The chart of Martin ratio for APYX, currently valued at -0.76, compared to the broader market-5.000.005.0010.0015.0020.0025.00-0.7613.27
APYX
^GSPC

The current Apyx Medical Corporation Sharpe ratio is -0.37. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Apyx Medical Corporation with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.37
2.07
APYX (Apyx Medical Corporation)
Benchmark (^GSPC)

Dividends

Dividend History


Apyx Medical Corporation doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-90.46%
-1.91%
APYX (Apyx Medical Corporation)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Apyx Medical Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Apyx Medical Corporation was 94.20%, occurring on Aug 7, 2024. The portfolio has not yet recovered.

The current Apyx Medical Corporation drawdown is 90.46%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-94.2%Nov 23, 2021679Aug 7, 2024
-86.58%Sep 1, 1995691Jul 15, 1999743Sep 9, 20031434
-83.88%Dec 28, 20062367May 31, 20161166Jan 15, 20213533
-51.47%Nov 17, 2003460Sep 20, 2005153May 1, 2006613
-26.83%Aug 2, 200612Aug 17, 200647Oct 24, 200659

Volatility

Volatility Chart

The current Apyx Medical Corporation volatility is 33.46%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%JulyAugustSeptemberOctoberNovemberDecember
33.46%
3.82%
APYX (Apyx Medical Corporation)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Apyx Medical Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Apyx Medical Corporation.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab